Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383669801> ?p ?o ?g. }
- W4383669801 endingPage "213" @default.
- W4383669801 startingPage "201" @default.
- W4383669801 abstract "Objective: The present investigation aims to develop nano in situ gels of bevacizumab and evaluate their safety and efficacy. Methods: Nanoparticles were designed using the desolvation and double emulsion solvent evaporation technique. The hen’s egg test: chorioallantoic membrane (HET-CAM) assay was adopted to evaluate the anti-angiogenesis and irritancy potential of prepared nano in situ gel. Computational docking study carried out using glide module of Schrodinger software. Results: The FT-IR study showed no interaction between the components. The drug-loaded nanoparticle showed particle size in the range of 369±5.3 to 410±3.5, followed by PDI 0.41±0.1 to 0.73±0.1, and ζ–Potential-13±2.3 to-9±3.4. The entrapment efficiency of nanoparticles was found in between the range of 72.35±1.4 to 87.22±1.1, followed by loading efficiency of 8.81±0.3 to 12.78±0.7. The FE-SEM studies resulted in an irregular pattern of aggregated particles. The spherical shape of the particles was confirmed through the HR-TEM study. The nano in situ gel exhibited pH in the range of 7.2±0.2 to 7.3±0.1 followed by a viscosity of 325.2±8.7 to 498.7±5.8 mPa. s. CAM assays revealed the safety and anti-angiogenesis activity of the developed formulation. All different concentrations of in situ gels of bevacizumab showed a significant anti-angiogenic effect. The outcome of the molecular docking study revealed the well-binding capacity of bevacizumab with vascular endothelial growth factor (-7.325) and human serum albumin (-5.620) residues. Conclusion: The above outcomes improved our perception regarding the anti-angiogenic activity and safety of nano-in situ gels of bevacizumab. Overall, these findings denoted that implementing the current idea in the therapy of ocular angiogenesis might be a promising platform for better treatment." @default.
- W4383669801 created "2023-07-09" @default.
- W4383669801 creator A5008441671 @default.
- W4383669801 creator A5020808355 @default.
- W4383669801 creator A5047691490 @default.
- W4383669801 date "2023-07-07" @default.
- W4383669801 modified "2023-09-25" @default.
- W4383669801 title "DEVELOPMENT OF NANO IN SITU GELS OF BEVACIZUMAB FOR THE TREATMENT OF OCULAR ANGIOGENESIS: IN VITRO ASSESSMENT OF ANTI-ANGIOGENESIS ACTIVITY AND MOLECULAR DOCKING ANALYSIS" @default.
- W4383669801 cites W1004096295 @default.
- W4383669801 cites W1580190537 @default.
- W4383669801 cites W1963920770 @default.
- W4383669801 cites W1974005309 @default.
- W4383669801 cites W1982631880 @default.
- W4383669801 cites W1983622721 @default.
- W4383669801 cites W1983634850 @default.
- W4383669801 cites W1997409302 @default.
- W4383669801 cites W1998761071 @default.
- W4383669801 cites W2006960905 @default.
- W4383669801 cites W2011333615 @default.
- W4383669801 cites W2016091072 @default.
- W4383669801 cites W2022192661 @default.
- W4383669801 cites W2027442301 @default.
- W4383669801 cites W2035861952 @default.
- W4383669801 cites W2037799666 @default.
- W4383669801 cites W2045422540 @default.
- W4383669801 cites W2045914287 @default.
- W4383669801 cites W2058934794 @default.
- W4383669801 cites W2065007687 @default.
- W4383669801 cites W2070120141 @default.
- W4383669801 cites W2074417814 @default.
- W4383669801 cites W2076305305 @default.
- W4383669801 cites W2076313217 @default.
- W4383669801 cites W2078916806 @default.
- W4383669801 cites W2091170554 @default.
- W4383669801 cites W2132594474 @default.
- W4383669801 cites W2137297789 @default.
- W4383669801 cites W2140848006 @default.
- W4383669801 cites W2149565435 @default.
- W4383669801 cites W2266013672 @default.
- W4383669801 cites W2296597338 @default.
- W4383669801 cites W2338525980 @default.
- W4383669801 cites W2586886309 @default.
- W4383669801 cites W2605781891 @default.
- W4383669801 cites W2605966271 @default.
- W4383669801 cites W2618565854 @default.
- W4383669801 cites W2625391125 @default.
- W4383669801 cites W2759854402 @default.
- W4383669801 cites W2761604622 @default.
- W4383669801 cites W2790912883 @default.
- W4383669801 cites W2791537102 @default.
- W4383669801 cites W2794318720 @default.
- W4383669801 cites W2888347454 @default.
- W4383669801 cites W2899211111 @default.
- W4383669801 cites W2911895843 @default.
- W4383669801 cites W2937418703 @default.
- W4383669801 cites W3034690662 @default.
- W4383669801 cites W3042157433 @default.
- W4383669801 cites W3091351497 @default.
- W4383669801 cites W3092308524 @default.
- W4383669801 cites W3099437660 @default.
- W4383669801 cites W3110220146 @default.
- W4383669801 cites W3114991116 @default.
- W4383669801 cites W3136505420 @default.
- W4383669801 cites W3139819882 @default.
- W4383669801 cites W3197284659 @default.
- W4383669801 cites W3199755552 @default.
- W4383669801 cites W3206306044 @default.
- W4383669801 cites W4200568039 @default.
- W4383669801 cites W4226115320 @default.
- W4383669801 cites W4247767671 @default.
- W4383669801 cites W4283213479 @default.
- W4383669801 cites W4288424532 @default.
- W4383669801 cites W4324351632 @default.
- W4383669801 doi "https://doi.org/10.22159/ijap.2023v15i4.47860" @default.
- W4383669801 hasPublicationYear "2023" @default.
- W4383669801 type Work @default.
- W4383669801 citedByCount "0" @default.
- W4383669801 crossrefType "journal-article" @default.
- W4383669801 hasAuthorship W4383669801A5008441671 @default.
- W4383669801 hasAuthorship W4383669801A5020808355 @default.
- W4383669801 hasAuthorship W4383669801A5047691490 @default.
- W4383669801 hasBestOaLocation W43836698011 @default.
- W4383669801 hasConcept C12554922 @default.
- W4383669801 hasConcept C141071460 @default.
- W4383669801 hasConcept C147789679 @default.
- W4383669801 hasConcept C155672457 @default.
- W4383669801 hasConcept C159110408 @default.
- W4383669801 hasConcept C171250308 @default.
- W4383669801 hasConcept C178790620 @default.
- W4383669801 hasConcept C185592680 @default.
- W4383669801 hasConcept C187530423 @default.
- W4383669801 hasConcept C192562407 @default.
- W4383669801 hasConcept C202751555 @default.
- W4383669801 hasConcept C2776694085 @default.
- W4383669801 hasConcept C2777802072 @default.
- W4383669801 hasConcept C2777822432 @default.
- W4383669801 hasConcept C2780394083 @default.
- W4383669801 hasConcept C41685203 @default.